Dear colleagues,

The year of 2020 has been a difficult start for the unpredictable developments of the COVID-19 epidemic. The epidemic has seriously affected to health, social, financial issues and changed people ‘s daily routines. Thereby it also requires us to have quick responses to new types of epidemics that occur in the future.

Different from the rapid response to infectious diseases, cancer is classified as non-communicable disease, which means fighting cancer is a long-term process and facing a lot of challenges. Following the success of the 2017 cancer control conference, the International Conference on Cancer Control, ANCCA 2020 is scheduled to take place in Hanoi from October 28 to 30, 2020 but due to the complicated evolution of the COVID-19 epidemic, the conference will be rescheduled from October 28 to 30, 2021. This conference is continued focusing on the topic of prevention, screening for early detection of cancer, issues related to health economics & cancer prevention policy and treatment as well as aspects related to quality management in cancer control.

Accompanying the Asian National Cancer Center Alliance (ANCCA) with 14 members will be a special highlight for the 2021 Cancer Control Conference to become an important international event.

We hope the conference will provide opportunities for leading cancer centers in Asia to meet, share experiences, policies, practical lessons in cancer prevention and control in each country, open a prestigious and creative forum for scientists, young leaders in the future, doctors, health workers to exchange, discuss and give ideas which actually contribute to cancer prevention policies.

Once again, welcome to the 2nd International Conference on Cancer Control – ANCCA 2021.

Organizer of the 2nd International Conference on Cancer Control - Vietnam National Cancer Hospital

About Conference

The 2nd International Conference on Cancer Control - ANCCA 2021 will be held from 28th to 30th October, 2021 in Hanoi with the presence of members from Asia National Cancer Center Alliance (ANCCA). The conference aims at targeting cancer prevention strategic direction, opportinuties sharing, standard setting to improve caring quality and promote approaching treatment ability for patient.

Strategic Direction

Opportunity Sharing

Standard Setting

Approaching treatment increase

Conference Registration


Attend all sessions of the conference


Before October 25th, 2021



Attend CME courses and get certificate

USD 22/ person/ CME

Before October 15th, 2021


Program Information

Cancer control aims to reduce the incidence, morbidity and mortality of cancer and improve the quality of life of cancer patients in a defined population, through a systematic implementation of evidence-based interventions for prevention, early detection, diagnosis, treatment and palliative care. The purpose of the course is to provide the fundamental principles that guide the decisions and process it uses to periodically establish priorities in cancer policy and implement.

Lecturer: ANCCA

Next Generation Sequencing (NGS) allows more granular assessment of individual cancer risks and reactions to many medications. Cancer risk evaluation by NGS is becoming more popular and more available, allow setting up personalized genetic screenings (from a few to several genes) and clinical options, an important step towards individualized medicine. The course will describe the recent technological developments in NGS applied to the field of cancer risk screening.

Lecturer: to be updated

15:00 - 15:30

Break Time

Health technology assessment (HTA) is a form of policy analysis that helps decide what to fund and what not to fund. The course will briefly define the critical aspects of HTA assessment and also define what a cost-effectiveness analysis is and why economic modelling is the most appropriate tool to assess the cost-effectiveness of oncology products. We then present an overview of the general structure of an oncology cost-effectiveness model.

Lecturer: Health Strategy and Policy Institute - Hanoi University of Public Health

Clinical trials aimed to improve health and quality of life are the cornerstone of progress in medicine. Successful trials require teams of physicians, scientists, and statisticians. Vietnam NCH has developed a clinical trials center, which provides shared resources for many researchers and serves as a solution for training and mentoring new investigators and study teams. This course will discuss the creation of a clinical trials center and presents the advantages, disadvantages, and required building blocks for such a unit.

Lecturer: Dr. Dao Van Tu, Clinical Trials Center, National Cancer Hospital, Vietnam

08:30 – 09:00


Welcome Speech:

- Ministry of Health

- Assoc. Prof. Le Van QUANG, Director of Vietnam National Cancer Hospital

- ANCCA’s representative

Chairman: NCC Japan – NCC Korea – NCC Vietnam

ANCCA: a strong Asian hub for cancer control

The Asian National Cancer Centers Alliance (ANCCA) was established in 2005 to address the cancer burden faced by Asian countries, which account for half of the world’s cancer incidence. With 14 current members, ANCCA create a concrete action plan on collaboration that focus on training, research, cancer registry and clinical trials.

Speaker: ANCCA’s representative (TBC)

Assessment of National Cancer Control Plan (NCCP)

A national cancer plan is a strategic plan to control cancer based on the country’s cancer burden, cancer risk factor burden and the resources available to implement the plan in the context of the culture and health care system in that country. National cancer plans should be based on available data and an assessment of resource gaps in the country. It may assist in identifying areas for enhancement, improvement, or shed light on reasons for challenges that have been encountered.

Speaker: IARC Director (inviting)

10:15 – 10:30

Networking Break

National Cancer Control Plans in Asian countries

This session will encompass the entire cancer control continuum from prevention, early detection and diagnosis, treatment, survivorship to palliative care, research, health workforce, health information systems, governance and budget. A detailed discussion improves the understanding of strengths and limitations of current plans in Asians countries, providing strategic direction to national cancer control plans and to reducing the cancer burden.

Chairman: IARC Director – NCC Japan – NCC Korea – NCC China – NCC Indonesia

11:30 – 13:30

Lunch - Satellite workshops


Quality management is a key requirement to obtain the best care for cancer patients. Quality indicators are a tool in control and reflection about the given care and can be used for benchmarking. The development of an Accreditation Standards for cancer hospitals in Asian countries is needed.

Chairman: Simon Orberst, Cambridge Cancer Center (TBC)

Introduction to Quality Management and Assurance in Cancer Hospital

Speaker: Simon Orberst, Cambridge Cancer Center

Accreditation Standards and Guidelines: review and proposal for Asian countries

Speaker: NCC Japan 


A partnerships between governments, industry and civil society to provide affordable access to drugs is underway. New payment methods such as access programs and market-specific price discrimination are being implemented. We will touch upon the prices of oncology drugs regarding funding and availability.

Chairman: Prof. Tran Van THUAN, MOH  - Yasuhiro Fujiwaa, PMDA Japan (TBC)

The Cost of Oncology Drugs: Reasons and Solutions

Speaker: ANCCA 

Improving Access to Cancer Drugs

Speaker: Yasuhiro Fujiwaa, PMDA Japan (TBC)

15:00 – 17:00

ANCCA Annual Meeting (invited only)

18:00 – 21:00

Gala dinner

08:30 - 09:00



Cancer treatments were combined in new ways, optimal dosing and scheduling were identified for existing treatments, and adverse events were reduced. Also find out how the cancer hospital continued their comprehensive cancer control plan during COVID-19 pandemic.

Chairman: to be updated

Lung cancer: Aggressive Treatment

Speaker: Dr. Nguyen Thi Thai Hoa, Vietnam National Cancer Hospital

Breast cancer

Speaker: to be updated

ANCCA COVID-19 Cancer Study

Speaker: ANCCA


The future of medicine is data-driven and AI-enabled. Learn from others along the value-chain to understand how to effectively translate technology, data and analytic innovations into clinical practices and patient benefits.

Chairman: to be updated

AI & Big Data Application in Cancer Research

Speaker: to be updated

AI & Big Data Application in Cancer Care

Speaker: to be updated


10:30 - 10:45

Networking Break

10:45 - 11:30

ANCCA Annual meeting (invited only)

11:30 - 13:30

Lunch - Satellite workshops

To be updated

15:00 - 15:15

Networking break

To be updated

Key Speakers


We are welcome you to send us your abstracts

Vietnam National Cancer Institute - K Hospital cordially invites colleagues to present the report at The 2nd International Conference on Cancer Control - ANCCA 2021. The excellent papers will be selected and supported with conference fee.

Our Sponsors


Vietnam National Cancer Hospital

30 Cau Buou, Tan Trieu, Thanh Tri, Hanoi

Sponsor Registration Support


Conference Registration Support

info@ancca2020.vn; registration@ancca2020